{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:36:55Z","timestamp":1790707015407,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03492-1","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:06:51Z","timestamp":1759234011000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of KIF14 as a ferroptosis biomarker for predicting the prognosis and immunotherapy efficacy of bladder cancer"],"prefix":"10.1007","volume":"16","author":[{"given":"Xiaocheng","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyi","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"1","key":"3492_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21708.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3492_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","volume":"12","author":"Y Mou","year":"2019","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34. https:\/\/doi.org\/10.1186\/s13045-019-0720-y.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"3492_CR3","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35(6):830\u201349. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.002.","journal-title":"Cancer Cell"},{"issue":"8","key":"3492_CR4","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1111\/jcmm.14511","volume":"23","author":"T Xu","year":"2019","unstructured":"Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W, Wang J. Molecular mechanisms of ferroptosis and its role in cancer therapy. J Cell Mol Med. 2019;23(8):4900\u201312. https:\/\/doi.org\/10.1111\/jcmm.14511.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3492_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13045-020-00946-7","volume":"13","author":"R Tang","year":"2020","unstructured":"Tang R, Xu J, Zhang B, Liu J, Liang C, Hua J, Meng Q, Yu X, Shi S. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity. J Hematol Oncol. 2020;13(1):110. https:\/\/doi.org\/10.1186\/s13045-020-00946-7.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"3492_CR6","doi-asserted-by":"publisher","first-page":"e139434","DOI":"10.1172\/JCI139434","volume":"131","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Lim SO, Yan M, Hsu JL, Yao J, Wei Y, Chang SS, Yamaguchi H, Lee HH, Ke B, Hsu JM, Chan LC, Hortobagyi GN, Yang L, Lin C, Yu D, Hung MC. TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clin Invest. 2021;131(8):e139434. https:\/\/doi.org\/10.1172\/JCI139434.","journal-title":"J Clin Invest"},{"issue":"1","key":"3492_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1007\/s12672-024-01575-z","volume":"15","author":"DM Song","year":"2024","unstructured":"Song DM, Feng K, Luo WF, Lv DS, Zhou LP, He YB, Jin Y. Predicting survival in bladder cancer with a novel apoptotic gene-related prognostic model. Discov Oncol. 2024;15(1):702.","journal-title":"Discov Oncol"},{"issue":"7693","key":"3492_CR8","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R, Jhunjhunwala S, Banchereau R, Yang Y, Guan Y, Chalouni C, Ziai J, \u015eenbabao\u011flu Y, Santoro S, Sheinson D, Hung J, Giltnane JM, Pierce AA, Mesh K, Lianoglou S, Riegler J, Carano RAD, Eriksson P, H\u00f6glund M, Somarriba L, Halligan DL, van der Heijden MS, Loriot Y, Rosenberg JE, Fong L, Mellman I, Chen DS, Green M, Derleth C, Fine GD, Hegde PS, Bourgon R, Powles T. TGF\u03b2 attenuates tumour response to PD-L1 Blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138. https:\/\/doi.org\/10.1038\/nature25501.","journal-title":"Nature"},{"issue":"1","key":"3492_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s12672-025-02484-5","volume":"16","author":"Z Wang","year":"2025","unstructured":"Wang Z, Dai Z, Gao Y, Zhao Z, Li Z, Wang L, Gao X, Qiu Q, Qiu X, Liu Z. Development of a machine learning-based predictive risk model combining fatty acid metabolism and ferroptosis for immunotherapy response and prognosis in prostate cancer. Discov Oncol. 2025;16(1):744.","journal-title":"Discov Oncol"},{"issue":"1","key":"3492_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12672-025-02151-9","volume":"16","author":"K Liu","year":"2025","unstructured":"Liu K, Yu J, Huang X, Gao H, Wang J. WGCNA and ferroptosis genes in OSCC: unraveling prognostic biomarkers and therapeutic targets. Discov Oncol. 2025;16(1):379.","journal-title":"Discov Oncol"},{"issue":"1","key":"3492_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/s12967-025-06661-6","volume":"23","author":"B Lu","year":"2025","unstructured":"Lu B, Liu Y, Ji G, Yao Y, Yang Z, Zhu B, Wang L, Dong K, Li Y, Shi J, He J, Huang R, Zhou W, Cui X, Pan X, Cui X. Construction of a prostate adenocarcinoma molecular classification: integrating Spatial transcriptomics with retrospective cohort validation. J Transl Med. 2025;23(1):717. https:\/\/doi.org\/10.1186\/s12967-025-06661-6.","journal-title":"J Transl Med"},{"key":"3492_CR12","doi-asserted-by":"publisher","first-page":"568397","DOI":"10.3389\/fendo.2021.568397","volume":"12","author":"C Shen","year":"2021","unstructured":"Shen C, Liu J, Yang X, Jiao W, Wang Y. Development and validation of an m6A RNA methylation Regulators-Based signature for predicting the prognosis of adrenocortical carcinoma. Front Endocrinol (Lausanne). 2021;12:568397. https:\/\/doi.org\/10.3389\/fendo.2021.568397.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3492_CR13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s12672-024-01363-9","volume":"15","author":"B Wang","year":"2024","unstructured":"Wang B, Wei Z, Xu M, Shu H, Fan Z. Identification of key ferroptosis genes and subtypes in kidney renal clear cell carcinoma. Discov Oncol. 2024;15(1):492.","journal-title":"Discov Oncol"},{"key":"3492_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_12.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"3492_CR15","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s12672-024-01650-5","volume":"15","author":"C Xiao","year":"2024","unstructured":"Xiao C, Zhang X, Hou B, Wan P, Cao Z, Rao X. CYFIP2: potential pancreatic cancer biomarker and immunotherapeutic target. Discov Oncol. 2024;15(1):847.","journal-title":"Discov Oncol"},{"key":"3492_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"3492_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12672-024-01401-6","volume":"15","author":"QX Yu","year":"2024","unstructured":"Yu QX, Wu RC, Wang J, Tuo ZT, Yang J, Zhang YP, Jin J, Yuan Q, Wang CN, Feng DC, Li DX. Exploring the role of ADAMTSL2 across multiple cancer types: A pan-cancer analysis and validated in colorectal cancer. Discov Oncol. 2024;15(1):538.","journal-title":"Discov Oncol"},{"issue":"1","key":"3492_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12935-020-01627-8","volume":"20","author":"C Shen","year":"2020","unstructured":"Shen C, Liu J, Wang L, Liang Z, Niu H, Wang Y. Identification of metabolism-associated genes and construction of a prognostic signature in bladder cancer. Cancer Cell Int. 2020;20(1):538. https:\/\/doi.org\/10.1186\/s12935-020-01627-8.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3492_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","volume":"19","author":"B Zhang","year":"2020","unstructured":"Zhang B, Wu Q, Li B, Wang D, Wang L, Zhou YL. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer. 2020;19(1):53. https:\/\/doi.org\/10.1186\/s12943-020-01170-0.","journal-title":"Mol Cancer"},{"issue":"1","key":"3492_CR20","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s12672-025-03297-2","volume":"16","author":"J Huang","year":"2025","unstructured":"Huang J, Wang Q, Li Z, Huang X, Wang W, Liu J. Identification and validation of LDHA and SLC16A1 for predicting prognosis and diagnosis in lower-grade glioma. Discov Oncol. 2025;16(1):1511. https:\/\/doi.org\/10.1007\/s12672-025-03297-2.","journal-title":"Discov Oncol"},{"issue":"6352","key":"3492_CR21","doi-asserted-by":"publisher","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen M, Zhang C, Lee S, Sj\u00f6stedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, Sanli K, von Feilitzen K, Oksvold P, Lundberg E, Hober S, Nilsson P, Mattsson J, Schwenk JM, Brunnstr\u00f6m H, Glimelius B, Sj\u00f6blom T, Edqvist PH, Djureinovic D, Micke P, Lindskog C, Mardinoglu A, Ponten F. A pathology atlas of the human cancer transcriptome. Science. 2017;357(6352):eaan2507.","journal-title":"Science"},{"issue":"11\u201312","key":"3492_CR22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s10495-020-01638-w","volume":"25","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wei Z, Pan K, Li J, Chen Q. The function and mechanism of ferroptosis in cancer. Apoptosis. 2020;25(11\u201312):786\u201398. https:\/\/doi.org\/10.1007\/s10495-020-01638-w.","journal-title":"Apoptosis"},{"issue":"9","key":"3492_CR23","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1136\/gutjnl-2019-318419","volume":"68","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, Li CW, Lim SO, Sheng YY, Zhang Y, Li JH, Luo Q, Zheng Y, Zhao Y, Lu L, Jia HL, Hung MC, Dong QZ, Qin LX. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 Blockade. Gut. 2019;68(9):1653\u201366. https:\/\/doi.org\/10.1136\/gutjnl-2019-318419.","journal-title":"Gut"},{"issue":"1","key":"3492_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13046-020-01786-6","volume":"40","author":"W Fang","year":"2021","unstructured":"Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H, Zeng Q, Wang Y, Jin F, Chai C, Chen T. Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8\u2009+\u2009T cell exclusion. J Exp Clin Cancer Res. 2021;40(1):4. https:\/\/doi.org\/10.1186\/s13046-020-01786-6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3492_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41467-019-08352-5","volume":"10","author":"N Rosenzweig","year":"2019","unstructured":"Rosenzweig N, Dvir-Szternfeld R, Tsitsou-Kampeli A, Keren-Shaul H, Ben-Yehuda H, Weill-Raynal P, Cahalon L, Kertser A, Baruch K, Amit I, Weiner A, Schwartz M. PD-1\/PD-L1 checkpoint Blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model. Nat Commun. 2019;10(1):465. https:\/\/doi.org\/10.1038\/s41467-019-08352-5.","journal-title":"Nat Commun"},{"issue":"8","key":"3492_CR26","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1093\/annonc\/mdw217","volume":"27","author":"JM Kim","year":"2016","unstructured":"Kim JM, Chen DS. Immune escape to PD-L1\/PD-1 blockade: seven steps to success (or failure). Ann Oncol. 2016;27(8):1492\u2013504. https:\/\/doi.org\/10.1093\/annonc\/mdw217.","journal-title":"Ann Oncol"},{"issue":"2","key":"3492_CR27","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.apsb.2021.07.016","volume":"12","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zou L, Liao H, Luo J, Yang T, Wu J, Chen W, Wu K, Cen S, Lv D, Shu F, Yang Y, Li C, Li B, Mao X. Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8\u2009+\u2009T cell-mediated ferroptosis in castration-resistant prostate cancer. Acta Pharm Sin B. 2022;12(2):692\u2013707. https:\/\/doi.org\/10.1016\/j.apsb.2021.07.016.","journal-title":"Acta Pharm Sin B"},{"key":"3492_CR28","doi-asserted-by":"publisher","unstructured":"Liao P, Wang W, Wang W, Kryczek I, Li X, Bian Y, Sell A, Wei S, Grove S, Johnson JK, Kennedy PD, Gij\u00f3n M, Shah YM, Zou W. CD8\u2009+\u2009T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022.15:S1535-6108(22)00036-8. https:\/\/doi.org\/10.1016\/j.ccell.2022.02.003","DOI":"10.1016\/j.ccell.2022.02.003"},{"issue":"1","key":"3492_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbadis.2018.10.039","volume":"1865","author":"Z Yang","year":"2019","unstructured":"Yang Z, Li C, Yan C, Li J, Yan M, Liu B, Zhu Z, Wu Y, Gu Q. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer. Biochim Biophys Acta Mol Basis Dis. 2019;1865(1):181\u201392. https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.039.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"3492_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3892\/ijo.2019.4926","volume":"56","author":"B Ling","year":"2020","unstructured":"Ling B, Liao X, Huang Y, Liang L, Jiang Y, Pang Y, Qi G. Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments. Int J Oncol. 2020;56(1):193\u2013205. https:\/\/doi.org\/10.3892\/ijo.2019.4926.","journal-title":"Int J Oncol"},{"issue":"11","key":"3492_CR31","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1158\/1078-0432.CCR-07-0393","volume":"13","author":"TW Corson","year":"2007","unstructured":"Corson TW, Zhu CQ, Lau SK, Shepherd FA, Tsao MS, Gallie BL. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clin Cancer Res. 2007;13(11):3229\u201334. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0393.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"3492_CR32","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3892\/ijo.2018.4546","volume":"53","author":"ZZ Wang","year":"2018","unstructured":"Wang ZZ, Yang J, Jiang BH, Di JB, Gao P, Peng L, Su XQ. KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer. Int J Oncol. 2018;53(5):1939\u201352. https:\/\/doi.org\/10.3892\/ijo.2018.4546.","journal-title":"Int J Oncol"},{"key":"3492_CR33","doi-asserted-by":"publisher","first-page":"13241","DOI":"10.2147\/CMAR.S285367","volume":"12","author":"C Cheng","year":"2020","unstructured":"Cheng C, Wu X, Shen Y, Li Q. KIF14 and KIF23 promote cell proliferation and chemoresistance in HCC cells, and predict worse prognosis of patients with HCC. Cancer Manag Res. 2020;12:13241\u201357. https:\/\/doi.org\/10.2147\/CMAR.S285367.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3492_CR34","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1186\/s12967-024-05714-6","volume":"22","author":"H Ye","year":"2024","unstructured":"Ye H, Ding X, Lv X, Du Y, Guo R, Qiu J, Li R, Cao L. KLF14 directly downregulates the expression of GPX4 to exert antitumor effects by promoting ferroptosis in cervical cancer. J Transl Med. 2024;22(1):923. https:\/\/doi.org\/10.1186\/s12967-024-05714-6.","journal-title":"J Transl Med"},{"issue":"5","key":"3492_CR35","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1038\/emm.2014.23","volume":"46","author":"H Xu","year":"2014","unstructured":"Xu H, Choe C, Shin SH, Park SW, Kim HS, Jung SH, Yim SH, Kim TM, Chung YJ. Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma. Exp Mol Med. 2014;46(5):e97. https:\/\/doi.org\/10.1038\/emm.2014.23.","journal-title":"Exp Mol Med"},{"issue":"17","key":"3492_CR36","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41388-023-02661-2","volume":"42","author":"W Jiang","year":"2023","unstructured":"Jiang W, Wang J, Yang X, Shan J, Zhang Y, Shi X, Wang Y, Chenyan A, Chang J, Wang Y, Yu Y, Li C, Li X. KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1\/YBX1 mediated NF-\u03baB pathway in cholangiocarcinoma. Oncogene. 2023;42(17):1392\u2013404. https:\/\/doi.org\/10.1038\/s41388-023-02661-2.","journal-title":"Oncogene"},{"issue":"3","key":"3492_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.neo.2014.03.008","volume":"16","author":"SM Singel","year":"2014","unstructured":"Singel SM, Cornelius C, Zaganjor E, Batten K, Sarode VR, Buckley DL, Peng Y, John GB, Li HC, Sadeghi N, Wright WE, Lum L, Corson TW, Shay JW. KIF14 promotes AKT phosphorylation and contributes to chemoresistance in triple-negative breast cancer. Neoplasia. 2014;16(3):247\u201356. https:\/\/doi.org\/10.1016\/j.neo.2014.03.008. 256.e2.","journal-title":"Neoplasia"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03492-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03492-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03492-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:06:51Z","timestamp":1759234011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03492-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3492"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03492-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Second Hospital of Tianjin Medical University. This study was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all subjects or, if subjects are under 18, from a parent and\/or legal guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1786"}}